These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17961177)

  • 1. Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
    Pyrovolaki K; Mavroudi I; Papadantonakis N; Velegraki M; Ximeri M; Kalpadakis C; Gvazava G; Klaus M; Eliopoulos GD; Papadaki HA
    Eur J Haematol; 2007 Dec; 79(6):531-8. PubMed ID: 17961177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.
    Psyllaki M; Damianaki A; Gemetzi C; Pyrovolaki K; Eliopoulos GD; Papadaki HA
    Br J Haematol; 2006 Sep; 134(6):624-31. PubMed ID: 16938119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia.
    Papadaki HA; Damianaki A; Pontikoglou C; Pyrovolaki K; Eliopoulos DG; Stavroulaki E; Eliopoulos GD
    Br J Haematol; 2006 Mar; 132(5):637-9. PubMed ID: 16445839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10.
    Koumaki V; Damianaki A; Ximeri M; Pontikoglou C; Axioti F; Spanoudakis M; Eliopoulos GD; Papadaki HA
    Br J Haematol; 2006 Nov; 135(4):570-3. PubMed ID: 17054669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
    Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
    Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
    Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
    Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells.
    Papadaki HA; Giouremou K; Eliopoulos GD
    Eur J Haematol; 1999 Sep; 63(3):154-62. PubMed ID: 10485270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
    Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
    Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells.
    Papadaki HA; Eliopoulos AG; Kosteas T; Gemetzi C; Damianaki A; Koutala H; Bux J; Eliopoulos GD
    Blood; 2003 Apr; 101(7):2591-600. PubMed ID: 12517813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia.
    Koumaki V; Papadaki HA; Stefanaki K; Damianaki A; Gemetzi C; Katonis P; Vrentzos G; Eliopoulos GD
    Ann Hematol; 2003 Oct; 82(10):641-5. PubMed ID: 12904900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
    Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
    J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
    Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
    Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
    Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
    Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble c-kit ligand production by bone marrow stromal cells is independent of the degree of neutropenia in patients with chronic idiopathic neutropenia.
    Papadaki HA; Pontikoglou C; Stavroulaki E; Eliopoulos DG; Mavroudi I; Spanoudakis M; Eliopoulos GD
    Ann Hematol; 2006 Mar; 85(3):170-3. PubMed ID: 16391909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.
    Papadaki HA; Stamatopoulos K; Damianaki A; Gemetzi C; Anagnostopoulos A; Papadaki T; Eliopoulos AG; Eliopoulos GD
    Br J Haematol; 2005 Mar; 128(6):863-76. PubMed ID: 15755293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis.
    Mavroudi I; Papadaki V; Pyrovolaki K; Katonis P; Eliopoulos AG; Papadaki HA
    J Leukoc Biol; 2011 May; 89(5):771-83. PubMed ID: 21367977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease.
    Forsberg G; Hernell O; Hammarström S; Hammarström ML
    Int Immunol; 2007 Aug; 19(8):993-1001. PubMed ID: 17660501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.